Milk Dud? False Advertising Lawsuit Against Makers of Muscle Milk Illustrates Interplay Between Lanham Act, FTC and FDA

by Foley Hoag LLP - Trademark, Copyright & Unfair Competition

MM1In a lawsuit recently filed in the Southern District of Florida, Global Beverage Enterprises, Inc. (“Global”), the manufacturer of specialty carbonated beverages like Mr. Q. Cumber Sparkling Cucumber Beverage, brought Lanham Act claims against CytoSport, Inc., alleging false advertising of CytoSport’s popular Muscle Milk line of beverages.  The basis of the claim is that the Muscle Milk beverages contain no milk and, therefore, the product name is false and misleading.  If the case sounds vaguely familiar, it might be because this is not the first time Muscle Milk products have come under attack for alleged false advertising.  CytoSport has been defending similar claims for the past several years, and the unique history of those efforts sets the stage for a fascinating Lanham Act claim – one that may prove to be an uphill battle for Global.

The Prior False Advertising Proceeding

Five years ago, Nestle USA brought a competitor claim against CytoSport in the National Advertising Division of the Better Business Bureau (“NAD”), a self-regulatory forum.  Nestle’s allegations were virtually identical to those alleged by Global, including that the Muscle Milk products – despite the absence of milk – were sold in grocery and convenience stores alongside milk and other dairy products.  CytoSport declined to participate in the NAD proceeding, and the case was referred to the Federal Trade Commission (“FTC”).  (As discussed here, if an advertiser does not respond to a competitor’s challenge, NAD will generally refer the matter to the FTC.)

The FTC opened an investigation into possible violations of section 5 of the Federal Trade Commission Act, in particular “whether CytoSport’s product labeling and marketing for its ready-to-drink products could mislead consumers by implying that CytoSport’s products contain milk, when in fact they are water-based nutritional drinks.”  See FTC closing letter dated May 10, 2010.  But the FTC ultimately declined to recommend any enforcement action against CytoSport—in part because CytoSport agreed to modify its Muscle Milk labels to include a conspicuous disclosure on the front of the label that the product “Contains No Milk.”

The FDA’s Warning Letter

Just a year after the FTC closed its investigation, however, the Food and Drug Administration sent CytoSport a warning letter alleging, among other things, that the Muscle Milk product labels are misbranded within the meaning of Section 403(a)(1) of the Federal Food, Drug, and Cosmetic Act because the labels prominently feature the word “milk” when the products, in fact, contain no milk.  Although the federal statutes enforced by FTC and FDA are different, the FTC’s “misbranded” products analysis is similar to the FTC’s false advertising analysis, so the warning letter may indicate an inconsistency in how these two agencies view the disclosure.

Effectiveness of Disclosure

MM2In general, disclosures are considered effective where: (1) they are presented clearly and conspicuously; and (2) they are used to explain a claim, not cure a false claim.  Although these basic guidelines have been developed in the Lanham Act case law and NAD case reports, the FTC has been perhaps most instrumental in establishing the rules concerning the appropriate use of disclosures (including through last year’s updates to its Dot Com Disclosures).

Here, there is likely to be little dispute regarding whether the disclosure is clear and conspicuous.  As seen on the label, it appears immediately below the product name, is the same color as the product name, and is easy to read and understand.  As for whether the disclosure merely explains the “Muscle Milk” name (as opposed to curing a false claim), that is likely to be the subject of significant dispute.  If the product name is deemed a claim that the product contains milk, then the disclosure “contains no milk” could be perceived as curing an otherwise false claim.

On the other hand, didn’t the FTC already bless the disclosure when it closed its investigation of CytoSport, citing the disclosure as at least one factor in its decision? As a technical matter, the answer is “no.”  The FTC’s closing letter expressly states that the Commission’s decision not to recommend enforcement action should not be construed as a determination that no violation has occurred. Nevertheless, CytoSport is likely to argue that the FTC’s decision to close its investigation in 2010 without further action demonstrates that the “Contains No Milk” disclosure meets the basic guidelines for an effective disclosure.  After all, it is unlikely that the FTC would support its decision to close its investigation by specifically calling out a disclosure about which it had reservations.

Why It Matters

This case bears watching because it raises the question whether an advertiser can be held liable under the Lanham Act for advertising claims investigated by the FTC and for which the FTC declined to recommend enforcement action.  In addition, it is possible that the case will confront the question of the FDA and FTC’s overlapping jurisdiction regarding certain types of advertising claims (including those contained on many types of product labels).  While the FDA and FTC tend to coordinate their efforts on cases of common interest, the procedural history of this case raises a potential inconsistency, and it will be interesting to see whether the court defers to one agency or the other in resolving the case.



Written by:

Foley Hoag LLP - Trademark, Copyright & Unfair Competition

Foley Hoag LLP - Trademark, Copyright & Unfair Competition on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.